Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...

“By exploring pre-cancer biology and building on GSK’s expertise in the science of the immune system ... Medicine to drive ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well-being of all.

Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford University. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring ...

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 y ...

The Watson Family Charitable Trust has helped a range of local and overseas causes since it was launched in 2015, sparking a ...

In addition, TransCelerate executives and member organizations, such as Amgen, Eli Lilly, GSK, and more, will present 10 impactful sessions at the conference, addressing critical and relevant topics ...

Match Group (MTCH) shares declined when the online dating service provider removed its CEO and provided soft guidance as sales at Tinder and other units fell. Concerns about a trade war with China ...

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...

Approximately 80% of all GIST cases are driven by mutations in the KIT gene, and 90% of patients treated in the first-line develop new ... For GSK, the deal continues its strategy of building ...

Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...